{"id":10700,"name":"PsychoMetrics Analytics","purpose":"A tool to analyze clinical trial data related to mind-altering substances, focusing on isolating and quantifying the effects of placebo and 'knowcebo' phenomena.  It will provide researchers with advanced statistical models to improve the design and interpretation of future clinical trials.","profitable":1,"date_generated":"Friday March 2026 12:51","reference":"psycometrics-analytics-project","technology_advise":["Python","PostgreSQL","Medium"],"development_time_estimation_mvp_in_hours":120,"grade":7.2,"category":"healthcare","view_count":7,"similar_ideas":[{"id":10703,"name":"Psycho-Insight","grade":7.2,"category":"healthcare"},{"id":11235,"name":"Psychedelics Analytics Platform","grade":7.8,"category":"devtools"},{"id":8206,"name":"Psycho-Remodel Insights","grade":6.9,"category":"ai"},{"id":8512,"name":"Meta Youth Behavior Monitor","grade":5.8,"category":"social"},{"id":10656,"name":"Polymarket Data Insights","grade":6.8,"category":"data"}],"source_headline":"Mind-altering substances are (still) falling short in clinical trials"}